Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01116414 · ClinicalTrials.gov registry record
Molecular Phenotypes for Cystic Fibrosis Lung Disease
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 152
- Enrollment target
NCT01116414: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT01116414 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 152 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01116414 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 152 participants
- Enrollment target
Study Summary
The purpose of this study is to develop an integrated view of molecular mechanisms underlying CF lung disease severity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2009-07 |
| Est. Completion | 2023-10-25 |
What the finished NCT01116414 record still lists
NCT01116414 is an observational study that tracks outcomes without assigning an intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01116414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01116414 about?
NCT01116414 is a clinical study titled "Molecular Phenotypes for Cystic Fibrosis Lung Disease". The purpose of this study is to develop an integrated view of molecular mechanisms underlying CF lung disease severity.
What is the current status of trial NCT01116414?
This trial is currently completed. The enrollment target is 152 participants. The study started on 2009-07. Estimated completion is 2023-10-25.
Who is sponsoring clinical trial NCT01116414?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia